Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia

Head and Neck

Volumn 34, Issue 8, 2012, Pages 1136-1142

  Witsell, David L ^a,c   Stinnett, Sandra ^a   Chambers, Mark S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c AMERICAN ACADEMY OF OTOLARYNGOLOGY   (United States)

Author keywords

cevimeline; head and neck cancer; oral health; quality of life; xerostomia

Indexed keywords

CEVIMELINE;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEALTH; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MALE; MOUTH CANCER; MULTICENTER STUDY; OROPHARYNX CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SALIVARY GLAND; SALIVARY GLAND CANCER; TONGUE CANCER; XEROSTOMIA;

CARCINOMA, SQUAMOUS CELL; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MUSCARINIC AGONISTS; ORAL HEALTH; QUALITY OF LIFE; QUINUCLIDINES; RADIOTHERAPY; SALIVARY GLANDS; SEVERITY OF ILLNESS INDEX; THIOPHENES; XEROSTOMIA;

EID: 84864283281     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21894     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ,. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
2. Stephens LC, Schultheiss TE, Price RE, Ang KK, Peters J,. Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer 1991; 67: 1539-1543.
3. Chambers MS, Garden AS, Kies MS, Martin JW,. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 2004; 26: 796-807.
4. Vissink A, Mitchell JB, Baum BJ, et al. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys 2010; 78: 983-991.
5. Wijers O, Levendag P, Braaksma M, Boonzaaijer M, Visch LL, Schmitz PI,. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck 2002; 24: 737-747.
6. Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA,. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 2009; 74: 1-8.
7. Fox PC, van der Ven PF, Sonies BC, Weiffenbach JM, Baum BJ,. Xerostomia: evaluation of a symptom with increasing significance. J Am Dent Assoc 1985; 110: 519-525.
8. Dirix P, Nuyts S, Van den Bogaert W,. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 2006; 107: 2525-2534.
9. Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA,. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 69: 751-760.
10. Locker D,. Oral health and quality of life. Oral Health Prev Dent 2004; 2 Suppl 1: 247-253.
11. Ferguson MM,. Pilocarpine and other cholinergic drugs in the management of salivary gland dysfunction. Oral Surg Oral Med Oral Pathol 1993; 75: 186-191.
12. Ship JA, Hu K,. Radiotherapy-induced salivary dysfunction. Semin Oncol 2004; 31: 29-36.
13. Chambers MS,. Sjögren's syndrome. ORL Head Neck Nurs 2004; 22: 22-30.
14. Chambers MS, Posner M, Jones CU, et al. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 68: 1102-1109.
15. Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C, Eisbruch A,. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2006; 66: 445-453.
16. Slade GD,. Derivation and validation of a short-form oral health impact profile. Community Dent Oral Epidemiol 1997; 25: 284-290.
17. Awad MA, Locker D, Korner-Bitensky N, Feine JS,. Measuring the effect of intra-oral implant rehabilitation on health-related quality of life in a randomized controlled clinical trial. J Dent Res 2000; 79: 1659-1663.
18. Fife RS, Chase WF, Dore RK, et al. Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: a randomized trial. Arch Intern Med 2002; 162: 1293-1300.
19. Fox PC, Busch KA, Baum BJ,. Subjective reports of xerostomia and objective measures of salivary gland performance. J Am Dent Assoc 1987; 115: 581-584.
20. Kieffer JM, Hoogstraten J,. Linking oral health, general health, and quality of life. Eur J Oral Sci 2008; 116: 445-450.